Constructive Bio Wins Best Performing R&D Platform Development Company of the Year at the One Nucleus Awards

Constructive Bio has been named Best Performing R&D Platform Development Company of the Year at the One Nucleus Awards. The award recognises progress in advancing our synthetic genomics and engineered translation platform, and the work of the team in developing technologies that support future applications across health, materials and sustainability.

This reflects ongoing growth in our research capabilities and the development of tools that reprogram life’s genetic code. Grounded in the pioneering work of Professor Jason Chin, we combine synthetic genomics with engineered translation to move beyond the canonical 20-amino-acid framework. This approach enables the creation and scalable manufacture of peptides and proteins incorporating new-to-nature chemistries, including next-generation therapeutic molecules.